From: Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring
Priority 1 countries
Priority 2 countries
Priority 3 countries
All reporting countries
Number of suspected ACT
40 1
11 2
9 3
60
% of total number of suspected ACT
67%
18%
15%
100%